FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States
April 28, 2026Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the fastest-moving area of American metabolic and longevity medicine. MIAMI, FL, April 28th, 2026, FormBlends, a telehealth platform focused on medically supervised GLP-1 therapy and peptide research,…
